Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01186055 · ClinicalTrials.gov registry record

Brain Activity and Smoking Cessation

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
80
Enrollment target

NCT01186055: Completed study, sponsored by University of Pennsylvania.

NCT01186055 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01186055 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
80 participants
Enrollment target

Study Summary

In the current study, the investigators propose to test: (1) whether brain activation and connectivity in a resting state, assessed by ASL perfusion MRI, BOLD fMRI, and diffusion tensor imaging (DTI) predicts smoking relapse, and (2) whether brain activation, assessed by BOLD fMRI during performance of neurobehavioral probes for executive cognitive function, stress and cue reactivity, predicts smoking relapse.

Interventions

  • BEHAVIORAL Smoking Cessation Counseling

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2010-04
Est. Completion 2013-02

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01186055

The ClinicalTrials.gov registry entry for NCT01186055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Smoking Cessation Counseling is the first listed.

NCT01186055 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01186055 about?

NCT01186055 is a clinical study titled "Brain Activity and Smoking Cessation". In the current study, the investigators propose to test: (1) whether brain activation and connectivity in a resting state, assessed by ASL perfusion MRI, BOLD fMRI, and diffusion tensor imaging (DTI) predicts smoking relapse, and (2) whether brain activation, assessed by BOLD fMRI during performance...

What is the current status of trial NCT01186055?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2010-04. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01186055?

The interventions under investigation include: Smoking Cessation Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01186055?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.